Ocugen Provides Business Update with Fourth Quarter and Full Year 2024 Financial Results
Provided By GlobeNewswire
Last update: Mar 5, 2025
MALVERN, Pa., March 05, 2025 (GLOBE NEWSWIRE) -- Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today reported fourth quarter and full year 2024 financial results along with a general business update.
Read more at globenewswire.com
